Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Bent Frandsen — CEO

Roles

02.10.2025 – 01.07.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
01.07.2026ExpreS2ion Biotech Holding AB Stockholm
Share award
356,234—
Share award
356,234 units
↗
01.05.2026ExpreS2ion Biotech Holding AB Stockholm
New shares (subscription)
156,250SEK 1.60
SEK 250,000.00
↗
20.04.2026ExpreS2ion Biotech Holding AB Stockholm
SoldDisposal
192,125SEK 0.00
SEK 461.10
↗
20.04.2026ExpreS2ion Biotech Holding AB Stockholm
SoldDisposal
477SEK 0.01
SEK 5.25
↗
20.04.2026ExpreS2ion Biotech Holding AB Stockholm
SoldDisposal
121,230SEK 0.01
SEK 1,236.55
↗
20.04.2026ExpreS2ion Biotech Holding AB Stockholm
SoldDisposal
76,158SEK 0.01
SEK 807.27
↗
20.04.2026ExpreS2ion Biotech Holding AB Stockholm
SoldDisposal
56,588SEK 0.01
SEK 577.20
↗
02.10.2025ExpreS2ion Biotech Holding AB Stockholm
Option exercise
4,920SEK 14.65
SEK 72,078.00
↗
02.10.2025ExpreS2ion Biotech Holding AB Stockholm
Option exercise
196,800SEK 14.65
SEK 2,883,120.00
↗